Evidence map›Paper›PMID 42899068›Full record

ArticleJournal of cytology

Diagnostic Utility of FNAC in Cutaneous Adnexal Tumors: A Cytohistomorphological Correlation in 21 Cases.

Prakriti Shukla, Shilakshi Singh

Abstract read
In one paragraph

Article in Journal of cytology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Prakriti ShuklaDepartment of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Shilakshi SinghDepartment of Pathology, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Skin adnexal tumors (SATs) are uncommon neoplasms showing differentiation toward hair follicles, sebaceous glands, or sweat glands. Fine-needle aspiration cytology (FNAC) offers a rapid, minimally invasive diagnostic approach, though histopathology remains the gold standard. Aim: To correlate cytological features with histopathological findings in SATs. Materials and Methods: A prospective study was conducted over 18 months (July 2022-December 2023) in the Department of Pathology of a tertiary health care center. Twenty-one cases with both FNAC and histopathology were included. FNAC smears were stained with hematoxylin & eosin, Papanicolaou, and May-Grünwald-Giemsa. Biopsy specimens were processed and examined histologically. Special stains and immunohistochemistry were used when necessary. Cytohistological correlation was classified as complete, partial, or absent. Results: Of 517 skin biopsies, 29 were diagnosed as SATs on histopathology. The FNAC correlation was available in 21 cases only, and so these cases were included in the study. Nineteen were benign (90.5%), and two were malignant (9.5%). The group in their 20s was the most commonly affected (33%). Males outnumbered females (2:1). The head and neck region was the most common site. A complete correlation was observed in 42.8% of cases, partial correlation in 23.8%, and no correlation in 33.4%. Inadequate smears and overlapping morphology contributed to diagnostic discrepancies. Conclusion: FNAC, although limited in some cases, is valuable in differentiating benign from malignant cutaneous nodules. A clinico-cytohistological approach improves diagnostic accuracy and guides appropriate management.

Indexed as

Cytohistological correlationdiagnostic concordancefine-needle aspiration cytologyskin adnexal tumors

Identifiers

PMID42899068
PMCPMC13679960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.